Pharmaceutical Compositions and Pharmaceutical Products of Heterodimeric Human Interleukin-15 (hetIL-15)

text
October 28, 2021

Inventors

Ingo Fischer, Richard Gabriel

Assignees

  1. Novartis AG

Abstract

The disclosure is directed to stable pharmaceutical compositions comprising a heterodimer complex of IL-15 and IL-15Rα and pharmaceutical products comprising such compositions. The disclosure is also directed to the use of these compositions (e.g. as part of a kit having instructions for use) and pharmaceutical products for the treatment of lymphopenia, cancer, or infectious disease.

CovalX Technology Used

HM4

Source

Contact our Scientific Team to Start the Conversation

Request A Call
Back
Categories : Patents, HM5
text
PREVIOUS : Ultrafine Cellulose Nanofiber-Assisted Physical and Chemical Cross-Linking of MXene Sheets for Electromagnetic Interference Shielding
NEXT : Human Antibodies Against Severe Acute Respiratory Syndrome Coronavirus-2 (Sars-Cov-2)
text